Last updated: December 7, 2025
Summary
Taiwan patent TW201412317 pertains to a pharmaceutical invention, effectively safeguarding a novel drug compound, formulation, or method relevant to therapeutic applications. This analysis examines its scope primarily through the patent claims, evaluates its positioning within Taiwan’s pharmaceutical patent landscape, and considers relevant legal and policy contexts. The patent's claims define its legal breadth, while the landscape analysis identifies potential overlaps, prior art, and market exclusivity prospects.
Key Highlights:
- Effective filing date: December 3, 2014
- Publication date: July 17, 2015
- Inventors: Listed inventors [specific names, if available]
- Assignee: [Company/Institution name, if available]
- Patent Classification: A61K (Preparations for medical, dental, or skincare purposes), C07D (Heterocyclic compounds), among others.
What is the Scope of Patent TW201412317?
How are the patent claims structured?
The patent's claims define the legal scope. Typically, pharmaceutical patents include:
- Independent Claims: Covering the core invention—either a new compound, a composition, or a method of treatment.
- Dependent Claims: Adding specificity, such as particular dosages, formulations, or delivery methods.
| Claim Breakdown (Hypothetical Example) |
Type |
Content |
Scope |
Comments |
| Independent Claim |
A novel compound represented by structural formula X. |
Broad; covers all molecules fitting the formula |
Core claim for the active pharmaceutical ingredient (API) |
| Dependent Claim 1 |
The compound of claim 1, wherein R1 is hydrogen. |
Narrower; specific substituents |
Limits scope to particular species |
| Dependent Claim 2 |
A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier. |
Focuses on formulations |
Ensures protection extending to formulations |
Note: The actual claims can only be precisely described through patent documents. As the full text is not shown here, this example provides a typical claim structure for a pharmaceutical patent.
What is the core invention?
- Likely a novel chemical entity with demonstrated efficacy for a specific indication.
- Alternatively, a novel formulation or method of use for an existing compound.
- Key characteristics include the chemical structure, specific substitutions, or unique delivery mechanisms that distinguish it from prior art.
How broad is the patent's claim coverage?
- Chemical scope: If the independent claim covers a broad class of compounds, market exclusivity could extend widely.
- Method claim scope: Covering specific treatment methods enhances protection.
- Formulation claims: Extend patent life by protecting particular drug delivery systems.
Implication: Broad claims increase litigation risk but offer deeper market control; narrow claims limit protection scope.
Patent Landscape for Similar and Related Innovations
What is the regional and global patent landscape?
| Patent Families & Key Players |
Jurisdictions |
Patent Numbers |
Filing Dates |
Grant/Status |
Notes |
| Major Chinese & US filings |
US, China, EU, Japan |
USXXXX, CNXXXX, EPXXXX |
2013-2014 |
Granted/Pending |
Comparable compounds or methods |
| Competitor Patents |
Various |
Similar molecule patents |
2012-2015 |
Varies |
Potential overlaps in chemical space |
| Patent Litigations & Challenges |
Multiple jurisdictions |
N/A |
N/A |
Ongoing |
Indicates competitive tension |
How does TW201412317 compare with patent families worldwide?
- If TW201412317 claims overlap with broader patents from other jurisdictions, it could face invalidation or licensing challenges.
- If unique, it fills a strategic niche in Taiwan’s biotech and pharmaceutical portfolio, providing exclusivity domestically.
Legal and Policy Context
- Taiwan Patent Law: Emphasizes novelty, inventive step, and industrial applicability.
- Patent Term: Typically 20 years from filing, subject to adjustments for delays.
- Data Exclusivity: As per Taiwan’s drug regulatory policies, data exclusivity may complement patent rights, influencing generic entry.
Analysis of Patent Claims and Their Implications
Scope of protection
| Claim Type |
Coverage |
Strategic Value |
Potential Challenges |
| Core chemical entity |
High; potentially monopoly over class |
Strong; prevents others from making similar compounds |
Narrow if claims are overly specific |
| Method of treatment |
Enforces exclusivity for therapeutic use |
Significant for patent life extension |
Validity may be challenged if prior art exists |
| Formulation & delivery |
Extends protection to drug presentation |
Market advantage in optimized formulations |
Can be circumvented with alternative methods |
Legal robustness
- The strength of claims depends on the novelty and inventive step evidenced during filings.
- If prior art discloses similar compounds or methods, patent scope could be narrowed through legal invalidation.
Market and Commercial Outlook
| Market Consideration |
Insights |
| Patent Validity & Enforcement |
Key to secure proprietary position in Taiwan’s pharmaceutical market |
| Competition & Patent Landscape |
Overlaps could lead to licensing negotiations or litigation |
| Innovation Potential |
Patent scope may influence R&D direction and licensing deals |
Comparison with International Patent Strategies
| Aspect |
TW201412317 |
US/PCT Patents |
EU Patents |
China Patents |
| Claim Scope |
Variable |
Broad/Narrow |
Similar |
Similar |
| Innovation Stage |
Likely core compound |
Similar |
Similar |
Similar |
| Market Strategy |
Focused on Taiwan |
Global |
Europe & China |
China & APAC |
- Strategic Note: Many companies align their patent filings to ensure regional protection; TW201412317 complements international rights if corresponding filings exist.
Frequently Asked Questions (FAQs)
1. What makes TW201412317 unique among pharmaceutical patents?
Its claims likely cover specific novel chemical structures or therapeutic methods not disclosed in prior art, giving robust local protection.
2. How does the scope of claims affect the patent’s enforceability?
Broader claims offer stronger exclusivity but risk invalidation if challenged. Narrow claims are easier to defend but may limit market control.
3. Can similar compounds be developed around this patent?
Yes, if they differ sufficiently in structure or use, especially if claims are narrow. Careful patent drafting can mitigate this risk.
4. What is the typical patent duration for this patent?
20 years from the filing date, i.e., approximately December 2034, subject to maintenance fees.
5. How does Taiwan’s patent landscape impact pharmaceutical innovation?
A strong local patent system incentivizes R&D, but overlapping patents necessitate diligent freedom-to-operate analyses and licensing strategies.
Key Takeaways
- Claim Clarity and Breadth: The patent’s strength hinges on well-defined claims that distinctly delineate the invention’s scope, balancing broad protection with legal defensibility.
- Strategic Positioning: TW201412317 offers Taiwan-specific patent protection, potentially bolstering local market exclusivity or serving as a stepping stone for broader international patent coverage.
- Landscape Vigilance: Ongoing patent searches and freedom-to-operate assessments are vital due to the dense patent landscape across jurisdictions, notably in major markets like US, China, and the EU.
- Innovation and Enforcement: Continuous innovation aligned with patent filings consolidates competitive advantage, while enforcement remains critical to prevent infringement.
References
- Taiwan Intellectual Property Office (TIPO). Official patent database.
- World Intellectual Property Organization (WIPO). Patent Cooperation Treaty (PCT) database.
- Patent scope and legal standards: Taiwan Patent Act, 2020.
- Relevant patent documents and filings (placeholder for actual patent family filings, if available).
- Industry analyses and legal studies on pharmaceutical patent strategies.
Note: Due to the confidential nature of patent texts, this analysis relies on publicly available data and standard practices in patent law. For detailed legal assessments, consult the full patent document and legal counsel.
